The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

mevalonate     (3R)-3,5-dihydroxy-3-methyl- pentanoic acid

Synonyms: mevalonic acid, CHEMBL1794734, CHEBI:17710, CTK0E3502, LMFA01050352, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

High impact information on mevalonic acid

  • Studies were carried out in humans and in rhesus monkeys to determine the role of the kidneys in the metabolism of circulating mevalonic acid (MVA) [1].
  • RESULTS: Urinary MVA excretion rates (mumol/24h) were 1.82 +/- 0.21 in control subjects and 2.49 +/- 0.35 (P < 0.01 vs. control subjects) and 1.78 +/- 0.28 in patients before and after intensive insulin therapy, respectively [2].
  • LDL apheresis of 75% of the calculated plasma volume reduced LDL-cholesterol by 44% to 1.5 +/- 0.2 mmol/l without changing plasma MVA levels or L/C ratios [3].
  • A significant positive correlation was found between percentage decrease of MVA and non-esterified fatty acids following the insulin clamp in NIDDM (r = 0.83, P = 0.04) [4].
  • There was a highly significant positive correlation between ASR of VLDL apoB and plasma MVA (r = .88, P = .004), which persisted after adjusting for apo E phenotype [5].
 

Analytical, diagnostic and therapeutic context of mevalonic acid

  • Acute insulin infusion during the euglycemic clamp studies reduced mean plasma MVA concentrations at 120 and 180 min by 29 and 38%, respectively (P < 0.01 for both vs. baseline) [2].

References

  1. Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys. McNamara, D.J., Ahrens, E.H., Parker, T.S., Morrissey, K. J. Clin. Invest. (1985) [Pubmed]
  2. Effects of insulin on cholesterol synthesis in type II diabetes patients. Scoppola, A., Testa, G., Frontoni, S., Maddaloni, E., Gambardella, S., Menzinger, G., Lala, A. Diabetes Care (1995) [Pubmed]
  3. Upregulation of cholesterol synthesis after acute reduction of low density lipoprotein by apheresis in normocholesterolaemic subjects: evidence for a threshold effect. Pfohl, M., Naoumova, R.P., Neuwirth, C., Sussekov, A., Smykowski, J., Rendell, N.B., Taylor, G.W., Seif, F.J., Thompson, G.R. Atherosclerosis (1997) [Pubmed]
  4. Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects. Naoumova, R.P., Cummings, M.H., Watts, G.F., Rendell, N.B., Taylor, G.W., Sönksen, P.H., Thompson, G.R. Eur. J. Clin. Invest. (1996) [Pubmed]
  5. Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects. Watts, G.F., Naoumova, R., Cummings, M.H., Umpleby, A.M., Slavin, B.M., Sönksen, P.H., Thompson, G.R. Metab. Clin. Exp. (1995) [Pubmed]
 
WikiGenes - Universities